MiR‐21 regulates epithelial‐mesenchymal transition phenotype and hypoxia‐inducible factor‐1α expression in third‐sphere forming breast cancer stem cell‐like cells
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Cancer stem cells (CSC s) are predicted to be critical drivers of tumor progression due to their “stemness”, but the molecular mechanism of CSC s in regulating metastasis remains to be elucidated. Epithelial‐mesenchymal transition (EMT), hypoxia‐inducible factor (HIF)‐1α, and mi R‐21, all of which contribute to cell migration for metastasis, are interrelated with CSC s. In the present study, third‐sphere forming (3‐S) CSC‐like cells, which showed elevated CSC surface markers (ALDH 1+ and CD 44+/CD 24−/low) and sphereforming capacity as well as migration and invasion capacities, were cultured and isolated from breast cancer MCF‐7 parental cells, to evaluate the role of mi R‐21 in regulating the CSC‐like cell biological features, especially EMT. EMT, which was assessed by overexpression of mesenchymal cell markers (N‐cadherin, Vimentin, alpha‐smooth muscle actin [α‐SMA]) and suppression of epithelial cell marker (E‐cadherin), was induced in 3‐S CSC‐like cells. Moreover, both of HIF‐1α and miR‐21 were upregulated in the CSC‐like cells. Interestingly, antagonism of miR‐21 by antagomir led to reversal of EMT, downexpression of HIF‐1α, as well as suppression of invasion and migration, which indicates a key role of miR‐21 involved in regulate CSC‐associated features. In conclusion, we demonstrated that the formation of CSC‐like cells undergoing process of EMT‐like associated with overexpression of HIF‐1α, both of which are regulated by miR‐21. (Cancer Sci 2012; 103: 1058–1064)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
Biomarkers for epithelial-mesenchymal transitions
Zeisberg, M., & Neilson, E. G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36183 · Cited by 2,299
Si, M.-L., Zhu, S., Wu, H., Lu, Z., Wu, F., & Mo, Y.-Y. (2007) · Oncogene · doi:10.1038/sj.onc.1210083 · Cited by 1,600
Hypoxia requires Notch signaling to maintain the undifferentiated cell state
Gustafsson, M. V., Zheng, X., Pereira, T., Gradin, K., Jin, S., Lundkvist, J., Ruas, J. L., Poellinger, L., Lendahl, U., & Bondesson, M. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.09.010 · Cited by 1,109
Heddleston, J. M., Li, Z., McLendon, R. E., Hjelmeland, A. B., & Rich, J. N. (2009) · Cell Cycle · doi:10.4161/cc.8.20.9701 · Cited by 813
Charafe-Jauffret, E., Ginestier, C., Iovino, F., Tarpin, C., Diebel, M., Esterni, B., Houvenaeghel, G., Extra, J.-M., Bertucci, F., Jacquemier, J., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1630 · Cited by 732
Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α
Soeda, A., Park, M., Lee, D., Mintz, A., Androutsellis-Theotokis, A., McKay, R. D., Engh, J., Iwama, T., Kunisada, T., Kassam, A. B., et al. (2009) · Oncogene · doi:10.1038/onc.2009.252 · Cited by 656
Jögi, A., Øra, I., Nilsson, H., Lindeheim, Å., Makino, Y., Poellinger, L., Axelson, H., & Påhlman, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102660199 · Cited by 399
Bar, E. E., Lin, A., Mahairaki, V., Matsui, W., & Eberhart, C. G. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.091021 · Cited by 373
Cited by
Mimeault, M., & Batra, S. K. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12004 · Cited by 330
Donnarumma, E., Fiore, D., Nappa, M., Roscigno, G., Adamo, A., Iaboni, M., Russo, V., Affinito, A., Puoti, I., Quintavalle, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14752 · Cited by 317
van Schooneveld, E., Wildiers, H., Vergote, I., Vermeulen, P. B., Dirix, L. Y., & Van Laere, S. J. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0526-y · Cited by 296
Bao, B., Ahmad, A., Azmi, A. S., Ali, S., & Sarkar, F. H. (2013) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph1425s61 · Cited by 286
Oxygen control with microfluidics
Brennan, M. D., Rexius-Hall, M. L., Elgass, L. J., & Eddington, D. T. (2014) · Lab Chip · doi:10.1039/c4lc00853g · Cited by 188
Metadata
- Authors
- Han, M., Wang, Y., Liu, M., Bi, X., Bao, J., Zeng, N., Zhu, Z., Mo, Z., Wu, C., & Chen, X.
- Venue
- Cancer Science
- Publisher
- Wiley
- Published
- 2012-04-23
- Volume
- 103
- Issue
- 6
- Pages
- 1058-1064
- ISSN
- 1347-9032 (ISSN-L)
- 1349-7006
- OpenAlex
- W1971392922
- Cited by
- 129
- References
- 12
- FWCI
- 7.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MiR‐21 regulates epithelial‐mesenchymal transition phenotype and hypoxia‐inducible factor‐1α expression in third‐sphere forming breast cancer stem cell‐like cells. https://app.cochat.ai/papers/10.1111/j.1349-7006.2012.02281.x
- The paper
- Han, M., Wang, Y., Liu, M., Bi, X., Bao, J., Zeng, N., Zhu, Z., Mo, Z., Wu, C., & Chen, X. (2012). MiR‐21 regulates epithelial‐mesenchymal transition phenotype and hypoxia‐inducible factor‐1α expression in third‐sphere forming breast cancer stem cell‐like cells. Cancer Science. https://doi.org/10.1111/j.1349-7006.2012.02281.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.